About E3 ubiquitin-protein ligase TRIM13
E3 ubiquitin-protein ligase TRIM13 (TRIM13) is a protein
from Homo sapiens identified by UniProt accession
O60858, 407 residues long.
MolForge cross-references it against 0 known binders and
149 disease associations.
Target properties
| Protein name | E3 ubiquitin-protein ligase TRIM13 |
| UniProt accession | O60858 |
| Gene | TRIM13 |
| Organism | Homo sapiens |
| Length | 407 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (149)
Diseases linked to this target (Open Targets).
- vital capacity · score 0.28
- heel bone mineral density · score 0.28
- BMI-adjusted waist-hip ratio · score 0.28
- forced expiratory volume · score 0.26
- appendicular lean mass · score 0.24
- sex hormone-binding globulin measurement · score 0.23
- body height · score 0.22
- lean body mass · score 0.20
- whole body water mass · score 0.20
- bone quantitative ultrasound measurement · score 0.20
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60858-F1 | alphafold | PREDICTED | 79.27 | — |
Amino-acid sequence (407 residues)
MELLEEDLTC PICCSLFDDP RVLPCSHNFC KKCLEGILEG SVRNSLWRPA PFKCPTCRKE TSATGINSLQ VNYSLKGIVE KYNKIKISPK MPVCKGHLGQ PLNIFCLTDM QLICGICATR GEHTKHVFCS IEDAYAQERD AFESLFQSFE TWRRGDALSR LDTLETSKRK SLQLLTKDSD KVKEFFEKLQ HTLDQKKNEI LSDFETMKLA VMQAYDPEIN KLNTILQEQR MAFNIAEAFK DVSEPIVFLQ QMQEFREKIK VIKETPLPPS NLPASPLMKN FDTSQWEDIK LVDVDKLSLP QDTGTFISKI PWSFYKLFLL ILLLGLVIVF GPTMFLEWSL FDDLATWKGC LSNFSSYLTK TADFIEQSVF YWEQVTDGFF IFNERFKNFT LVVLNNVAEF VCKYKLL
Explore E3 ubiquitin-protein ligase TRIM13 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets